Efficacy of VEGF and VEGFR pathway inhibitors in the treatment of advanced gastric cancer / 国际肿瘤学杂志
Journal of International Oncology
;
(12): 393-396, 2017.
Article
in Chinese
| WPRIM
| ID: wpr-620917
ABSTRACT
Anti-neovascularization is an important research direction in the current treatment of gastric cancer.The inhibitors of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) are main research focus.At present,the inhibitors of the pathways of VEGF and VEGFR in the treatment of advanced gastric cancer include bevacizumab,ramucirumab,apatinib,regorafenib,sorafenib,et al.These drugs provide more possibilities for the treatment of advanced gastric cancer.
Full text:
Available
Index:
WPRIM (Western Pacific)
Language:
Chinese
Journal:
Journal of International Oncology
Year:
2017
Type:
Article
Similar
MEDLINE
...
LILACS
LIS